Chemical analysis of fresh and aged Australian e‐cigarette liquids

Colin P Mendelsohn and Alex D Wodak
Med J Aust 2022; 216 (8): . || doi: 10.5694/mja2.51480
Published online: 2 May 2022

To the Editor: Larcombe and colleagues1 report a range of potentially harmful chemicals in locally purchased e‐liquids, highlighting the need for rigorous Australian standards and regulation of vaping liquids. However, the biological and clinical significance of these findings is unclear.

  • Colin P Mendelsohn1
  • Alex D Wodak2

  • 1 Sydney, NSW
  • 2 St Vincent’s Hospital Sydney, Sydney, NSW


Competing interests:

Colin Mendelsohn has received funding from Pfizer, GlaxoSmithKline, Johnson and Johnson (Pacific), and Perrigo Australia for teaching, consulting and conference expenses. He is on the Pfizer’s Champix Advisory Board. He has not received any payments from electronic cigarette or tobacco companies. He was the founding chairman of the Australian Tobacco Harm Reduction Association (ATHRA), a health promotion charity established to raise awareness of safer alternatives to smoking, but stepped down from the board in January 2021. ATHRA received funding from the vape industry to establish the charity. Funding was ceased in March 2019. He is the author of a self‐funded book called Stop smoking start vaping. Alex Wodak is currently a director of ATHRA. He has not received any payments from electronic cigarette or tobacco companies.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.